Tag Archives: Drug

Albireo’s rare liver disease drug Bylvay scores back-to-back approvals in U.S., Europe

With a pair of approvals on both sides of the Atlantic, liver disease-focused biotech Albireo is off and running with its new medicine Bylvay. The oral drug, the first treatment for pruritus in patients with progressive familial intrahepatic cholestasis (PFIC), scored an FDA nod Tuesday and a European approval Monday. With the FDA’s blessing, Albireo is kicking off an “immediate”… Read More »

So far, so not-so-good: Neurologists slow to warm up to Biogen’s Alzheimer drug Aduhelm, study finds

Neurologists are thinking about Biogen’s newly approved Alzheimer’s drug, but so far it’s mostly just that—thoughts. While almost 90% of neurologists are moderately or highly aware of Aduhelm, only 3% have written prescriptions so far, according to Spherix Global Insights latest data. Even more concerning? Only about one fourth (27%) plan to prescribe the drug in… Read More »

Kirigami Stent for Localized Drug Delivery

Researchers at MIT have developed a kirigami-style stent that can provide localized drug delivery through needle-like projections that pop out when the stent is extended. The ‘spines’ on the stent’s surface deliver drug-loaded microparticles into the surrounding tissue, allowing for sustained drug release for an extended period. The technology is well suited to administering drugs… Read More »

FDA Approves Wegovy, a High-Dose Version of the Diabetes Drug Semaglutide for Use as Aid to Weight Loss

Wegovy — a high-dose version of the diabetes drug semaglutide — has been approved as a new aid to weight loss by the U.S. Food and Drug Administration. Studies funded by drug maker Novo Nordisk showed that participants who received weekly injections of the drug had an average weight loss of 15% and lost weight… Read More »

Fueled by COVID drug manufacturing revenues, CDMO Jubilant HollisterStier invests in upgrades, expansion

Since the onset of the coronavirus pandemic, Jubilant HollisterStier has been busy churning out COVID-19 treatments and more recently vaccines. Now it’s turning those revenues from the increased business into an investment in the future. The Spokane, Washington-based CDMO revealed a $ 92 million expansion plan this week that includes a high-speed injectable fill line with… Read More »